ElizabethCReedMD

Clinical Trials

• Neoadjuvant/Adjuvant Chemotherapy, Vaccine & Adjuvant Radiation Therapy in p53-Overexpressing Stage III Breast Cancer Start of enrollment: 2004 Jan 01

  Completed

  Phase 1, Phase 2

• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Start of enrollment: 2006 Apr 07

  Active, not recruiting

  Phase 3

• Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer Start of enrollment: 2004 Aug 31

  Completed

  Phase 1

• Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors Start of enrollment: 2006 Aug 15

  Completed

  Phase 1

• Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy Start of enrollment: 2004 Jan 01

  Terminated

  Phase 2

• Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women) Start of enrollment: 2006 May 01

  Completed

  Phase 2

• Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer Start of enrollment: 2008 May 15

  Active, not recruiting

  Phase 3

• Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery Start of enrollment: 2004 Apr 15

  Terminated

  Phase 2

• Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgery Start of enrollment: 2010 Mar 24

  Completed

  Phase 2

• A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation Start of enrollment: 2012 Aug 01

  Completed

  Phase 2, Phase 3

• Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer Start of enrollment: 2012 Dec 07

  Active, not recruiting

  Phase 2

• Join now to see all